| Q34669335 | A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression |
| Q31144747 | Adrenomedullin augments collateral development in response to acute ischemia |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q40611732 | Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation |
| Q36288905 | Angiogenic and antiangiogenic gene therapy |
| Q45859222 | Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment |
| Q39389842 | Angiogenic growth factors in myocardial infarction: a critical appraisal |
| Q51037168 | Beyond angioplasty: novel developments in interventional cardiology. |
| Q63246912 | Biocompatible, Purified mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine |
| Q37766172 | Bone marrow stem cells for the treatment of ischemic heart disease: a clinical trial review |
| Q34542255 | Catheter-based intramyocardial delivery (NavX) of adenovirus achieves safe and accurate gene transfer in pigs |
| Q37823425 | Cell therapy for cardiovascular disease: a comparison of methods of delivery |
| Q37206495 | Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells |
| Q35576409 | Clinical gene therapy for nonmalignant disease |
| Q37534643 | Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo |
| Q96685926 | Coronary vessel formation in development and disease: mechanisms and insights for therapy |
| Q35561306 | Current Perspectives in Therapeutic Myocardial Angiogenesis |
| Q36823697 | Current status of cardiovascular gene therapy |
| Q27004753 | Current stem cell delivery methods for myocardial repair |
| Q36931967 | Current strategies for myocardial gene delivery |
| Q35050717 | Defining the success of cardiac gene therapy: how can nuclear imaging contribute? |
| Q37876676 | Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease |
| Q84630375 | Different angiogenesis effect of mini-TyrRS/mini-TrpRS by systemic administration of modified siRNAs in rats with acute myocardial infarction |
| Q45711201 | Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors |
| Q53294337 | Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells |
| Q77361825 | Electromechanical assessment of left ventricular function following successful percutaneous coronary revascularization |
| Q37766161 | Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System |
| Q30383943 | Evaluation of extracorporeal shock wave therapy for refractory angina pectoris with quantitative analysis using cardiac magnetic resonance imaging: a short communication. |
| Q39275479 | Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography |
| Q45863301 | Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model |
| Q36617570 | Gene targeting in ischemic heart disease and failure: translational and clinical studies |
| Q37776515 | Gene therapy and angiogenesis in patients with coronary artery disease |
| Q35069562 | Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia |
| Q35141791 | Gene transfer as a tool to induce therapeutic vascular growth |
| Q36304278 | Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q35218706 | Gene-based therapeutic angiogenesis |
| Q37061103 | Growth factors and cell therapy in myocardial regeneration |
| Q28212550 | Growth factors improve latissimus dorsi muscle vascularization and trophicity after cardiomyoplasty |
| Q36681433 | HGF percutaneous endocardial injection induces cardiomyocyte proliferation and rescues cardiac function in pigs |
| Q35073982 | Increased susceptibility of hypertrophied hearts to ischemic injury |
| Q42464386 | Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction. |
| Q73209566 | Lake Tahoe invitation meeting 2002 |
| Q45981429 | Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. |
| Q37170581 | Localized targeting of biomaterials following myocardial infarction: a foundation to build on |
| Q36746521 | MR imaging in assessing cardiovascular interventions and myocardial injury |
| Q36108746 | MRI in guiding and assessing intramyocardial therapy. |
| Q34503413 | Myocardial gene therapy |
| Q36226806 | Non-viral vectors for gene therapy: clinical trials in cardiovascular disease |
| Q45878640 | Nonviral monocyte chemoattractant protein-1 gene transfer improves arteriogenesis after femoral artery occlusion |
| Q38113171 | Percutaneous approaches for efficient cardiac gene delivery. |
| Q35621815 | Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. |
| Q37864925 | Progress and prospects: hurdles to cardiovascular gene therapy clinical trials |
| Q35949666 | Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia |
| Q37085665 | Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium |
| Q35070251 | Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease |
| Q36813231 | Reduction of endothelial dysfunction following VEGF gene therapy |
| Q30946248 | Role of single photon emission computed tomography imaging in the evaluation of therapy for angina pectoris |
| Q37703070 | Site-specific gene therapy for cardiovascular disease. |
| Q45887964 | Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling |
| Q42762366 | Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization |
| Q35799722 | The evolution of heart gene delivery vectors |
| Q36596455 | The future of therapeutic myocardial angiogenesis |
| Q54389254 | The novel role of mast cells in the microenvironment of acute myocardial infarction. |
| Q35065245 | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. |
| Q33765479 | Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress |
| Q35080395 | Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review |
| Q36976439 | Therapeutic myocardial angiogenesis |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q35949643 | Therapeutic myocardial angiogenesis: past, present and future |
| Q78408682 | Therapeutic options for patients with chronic refractory angina pectoris |
| Q45883536 | Thoracoscopic monitoring for pericardial application of local drug or gene therapy |
| Q98613688 | Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy |
| Q30742596 | Transmyocardial coil implants: a novel approach to transmyocardial revascularization |
| Q35069886 | Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure |
| Q77626402 | VEGF therapy in heart disease: for better or for worse? |
| Q41790233 | Validation of transcatheter left ventricular electromechanical mapping for assessment of cardiac function and targeted transendocardial injection in a porcine ischemia-reperfusion model. |
| Q74070194 | Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? |
| Q35073986 | Vascular growth factors and angiogenesis in cardiac surgery. |
| Q30480221 | X-ray fused with magnetic resonance imaging (XFM) to target endomyocardial injections: validation in a swine model of myocardial infarction. |